机器人手术在喉癌中的作用。

The Role of Robotic Surgery in Laryngeal Cancer.

机构信息

ENT Department, Poole Hospital, Longfleet Road, Poole BH15 2JB, UK.

出版信息

Otolaryngol Clin North Am. 2023 Apr;56(2):313-322. doi: 10.1016/j.otc.2022.12.010.

DOI:10.1016/j.otc.2022.12.010

Abstract

Transoral robotic surgery (TORS) is a growing field in the treatment of head and neck cancers. Its benefits have been proven in the treatment of oropharynx HPV-positive squamous cell carcinoma, replacing chemoradiation as primary treatment of early-stage cancers or reducing the required radiation dosage, leading to improved functional outcomes without compromising oncological outcomes. There is also interest in the application of TORS for larynx cancer with the hope of achieving similar outcomes to replace open surgery or radiation treatments. Specifically, in the larynx, TORS can be used to resect supraglottic or glottic tumors.

摘要

经口机器人手术（TORS）是治疗头颈部癌症的一个新兴领域。其在治疗口咽 HPV 阳性鳞状细胞癌方面的优势已得到证实，可替代放化疗作为早期癌症的主要治疗方法，或减少所需的放射剂量，从而改善功能结果，而不影响肿瘤学结果。对于喉癌，TORS 的应用也引起了关注，希望能达到类似的效果，以替代开放性手术或放射治疗。具体来说，在喉部，TORS 可用于切除声门上或声门肿瘤。